Fujifilm Of Japan Adds Shares To Make Perseus Biotech Subsidiary
This article was originally published in PharmAsia News
Executive Summary
Japan's Fujifilm Holdings increased its share in Perseus Proteomics enough to control the biotechnology firm and enhance their joint development of drugs. Fujifilm held a 22 percent interest in Perseus, but bought enough additional shares to hold 77 percent ownership and make the biotech a subsidiary. Together, they already had been developing antibodies for the past three years. (Click here for more